UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
388.61
-5.32 (-1.35%)
At close: Aug 19, 2026, 4:00 PM EDT
388.50
-0.11 (-0.03%)
Pre-market: Aug 20, 2026, 8:56 AM EDT

UnitedHealth Group Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Premiums & Annuity Revenue
86,95687,56188,81188,97987,90586,53476,48377,44276,89777,98873,22872,33972,47472,78664,70064,49163,89664,07057,54756,967
Total Interest & Dividend Income
1,2231,1311,0441,1321,1081,0331,5511,6439971,0111,1799971,115798855513295367813503
Non-Insurance Activities Revenue
13,83513,25013,48413,29613,56413,03613,47512,63112,21111,90911,31110,35410,65110,2679,3989,1909,4969,3408,9618,703
Other Revenue
10,0189,77910,2739,7549,0398,9729,2989,1048,7508,8888,7098,6718,6638,0807,8346,7006,6456,3726,4226,164
112,032111,721113,612113,161111,616109,575100,807100,82098,85599,79694,42792,36192,90391,93182,78780,89480,33280,14973,74372,337
Revenue Growth (YoY)
0.37%1.96%12.70%12.24%12.91%9.80%6.76%9.16%6.41%8.55%14.06%14.17%15.65%14.70%12.26%11.83%12.63%14.18%12.64%11.09%
Policy Benefits
75,35873,48981,41879,95878,58573,41167,03565,95765,45865,73562,23159,55060,26859,84553,59152,63552,09352,52348,15947,302
Depreciation & Amortization
1,0401,0291,1171,0991,0841,0611,0411,0411,0209979741,0071,021970982828802788771796
Selling, General & Administrative
14,26815,39015,59715,22313,77813,59412,49413,28013,16214,07713,33913,85513,80913,62513,00911,66311,70911,40111,27210,725
Non-Insurance Activities Expense
13,37512,82312,68012,56613,01912,39012,46411,83411,34011,05610,1949,4239,7489,4058,3148,3068,5968,4878,0007,802
Total Operating Expenses
104,041102,731110,812108,846106,466100,45693,03492,11290,98091,86586,73883,83584,84683,84575,89673,43273,20073,19968,20266,625
Operating Income
7,9918,9902,8004,3155,1509,1197,7738,7087,8757,9317,6898,5268,0578,0866,8917,4627,1326,9505,5415,712
Interest Expense
-962-955-974-1,003-1,027-998-1,003-1,074-985-844-830-834-828-754-676-516-467-433-431-422
EBT Excluding Unusual Items
7,0298,0351,8263,3124,1238,1216,7707,6346,8907,0876,8597,6927,2297,3326,2156,9466,6656,5175,1105,290
Merger & Restructuring Charges
---2,420-----------------
Gain (Loss) on Sale of Assets
-61-72-126-83-41-1521-20-1,225-7,086----------
Pretax Income
6,9687,963-7203,2294,0828,1066,7917,6145,66516,8597,6927,2297,3326,2156,9466,6656,5175,1105,290
Income Tax Expense
1,2981,482-9386865101,6321,0071,3561,2441,2221,1841,6541,5721,5581,3071,5621,4661,3699191,099
Earnings From Continuing Ops.
5,6706,4812182,5433,5726,4745,7846,2584,421-1,2215,6756,0385,6575,7744,9085,3845,1995,1484,1914,191
Minority Interest in Earnings
-186-201-208-195-166-182-241-203-205-188-220-197-183-163-147-122-129-121-120-105
Net Income
5,4846,280102,3483,4066,2925,5436,0554,216-1,4095,4555,8415,4745,6114,7615,2625,0705,0274,0714,086
Net Income to Common
5,4846,280102,3483,4066,2925,5436,0554,216-1,4095,4555,8415,4745,6114,7615,2625,0705,0274,0714,086
Net Income Growth (YoY)
61.01%-0.19%-99.82%-61.22%-19.21%-1.61%3.66%-22.98%-14.58%11.00%7.97%11.62%16.95%28.78%18.85%3.39%84.04%28.82%
Shares Outstanding (Basic)
902908910906907912927923921922935926930933947935937941955943
Shares Outstanding (Diluted)
906910910908910918927930928922935936940943947948950954955955
Shares Change (YoY)
-0.44%-0.87%-1.83%-2.37%-1.94%-0.43%-0.86%-0.64%-1.28%-2.23%-1.27%-1.27%-1.05%-1.15%-0.84%-0.73%-0.63%-0.31%-0.62%-0.73%
EPS (Basic)
6.086.920.012.593.766.905.986.564.58-1.535.836.315.896.015.035.635.415.344.264.33
EPS (Diluted)
6.046.900.012.593.746.855.986.514.54-1.535.836.245.825.955.035.555.345.274.264.28
EPS Growth (YoY)
61.50%0.73%-99.91%-60.21%-17.62%-2.56%4.33%-21.99%-15.97%12.43%8.99%12.90%17.94%29.67%19.73%3.74%85.34%29.70%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
10,2538,1491605,0556,3024,5581,45712,9545,893401-6,1526,06410,20315,567-5,39917,8256,2144,7642,5236,951
Free Cash Flow Per Share
11.328.960.185.576.924.961.5713.936.350.43-6.586.4810.8516.51-5.7018.806.544.992.647.28
Dividend Per Share
2.3202.2102.2102.2102.2102.1002.1002.1002.1001.8801.8801.8801.8801.6501.6501.6501.6501.4501.4501.450
Dividend Growth (YoY)
4.98%5.24%5.24%5.24%5.24%11.70%11.70%11.70%11.70%13.94%13.94%13.94%13.94%13.79%13.79%13.79%13.79%16.00%16.00%16.00%
Operating Margin
7.13%8.05%2.46%3.81%4.61%8.32%7.71%8.64%7.97%7.95%8.14%9.23%8.67%8.80%8.32%9.22%8.88%8.67%7.51%7.90%
Profit Margin
4.90%5.62%0.01%2.08%3.05%5.74%5.50%6.01%4.26%-1.41%5.78%6.32%5.89%6.10%5.75%6.50%6.31%6.27%5.52%5.65%
Free Cash Flow Margin
9.15%7.29%0.14%4.47%5.65%4.16%1.44%12.85%5.96%0.40%-6.51%6.57%10.98%16.93%-6.52%22.04%7.74%5.94%3.42%9.61%
EBITDA
9,03110,0193,9175,4146,23410,1808,8149,7498,8958,9288,6639,5339,0789,0567,8738,2907,9347,7386,3126,508
EBITDA Margin
8.06%8.97%3.45%4.78%5.58%9.29%8.74%9.67%9.00%8.95%9.17%10.32%9.77%9.85%9.51%10.25%9.88%9.65%8.56%9.00%
D&A For EBITDA
1,0401,0291,1171,0991,0841,0611,0411,0411,0209979741,0071,021970982828802788771796
EBIT
7,9918,9902,8004,3155,1509,1197,7738,7087,8757,9317,6898,5268,0578,0866,8917,4627,1326,9505,5415,712
EBIT Margin
7.13%8.05%2.46%3.81%4.61%8.32%7.71%8.64%7.97%7.95%8.14%9.23%8.67%8.80%8.32%9.22%8.88%8.67%7.51%7.90%
Effective Tax Rate
18.63%18.61%-21.25%12.49%20.13%14.83%17.81%21.96%122200.00%17.26%21.50%21.75%21.25%21.03%22.49%22.00%21.01%17.98%20.77%
Revenue as Reported
112,032111,721113,215113,161111,616109,575100,807100,82098,85599,79694,42792,36192,90391,93182,78780,89480,33280,14973,74372,337
SEC Filings: 10-K · 10-Q